Drug Shortage Report for RIVA-LANSOPRAZOLE
| Report ID | 95042 |
| Drug Identification Number | 02422816 |
| Brand name | RIVA-LANSOPRAZOLE |
| Common or Proper name | Riva-Lansoprazole |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LANSOPRAZOLE |
| Strength(s) | 30MG |
| Dosage form(s) | CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-09-30 |
| Actual start date | 2019-09-30 |
| Estimated end date | Unknown |
| Actual end date | 2020-02-20 |
| Shortage status | Resolved |
| Updated date | 2021-12-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-12-02 | French | Compare |
| v4 | 2021-12-02 | English | Compare |
| v3 | 2019-10-01 | English | Compare |
| v2 | 2019-09-30 | French | Compare |
| v1 | 2019-09-30 | English | Compare |
Showing 1 to 5 of 5